Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| IVVD | Invivyd | $2.39 | $0.62 | 35.03% | 74.4M | $412.6M | $0.35$2.74 |
| TOI | Oncology Institute | $3.88 | $0.80 | 25.97% | 1.5M | $288.0M | $0.13$4.88 |
| SRRK | Scholar Rock | $37.52 | $7.45 | 24.78% | 148.8K | $2.9B | $22.71$46.98 |
| AMPG | AmpliTech Group | $3.28 | $0.62 | 23.31% | 2.7M | $54.9M | $0.78$6.43 |
| AVDL | Avadel Pharmaceuticals Plc | $23.07 | $3.83 | 19.91% | 4M | $1.9B | $6.38$23.39 |
| CMBM | Cambium Networks | $3.31 | $0.52 | 18.64% | 2.2M | $78.8M | $0.23$6.80 |
| MTC | MMTec | $3.00 | $0.47 | 18.57% | 987.2K | $63.7M | $0.25$3.89 |
| PGEN | Precigen | $4.58 | $0.72 | 18.52% | 101.7K | $1.2B | $0.65$5.23 |
| FIGR | Figure Technology Solutions | $39.53 | $4.94 | 14.28% | 1.3M | $7.3B | $25.00$49.50 |
| APLM | Apollomics | $23.72 | $2.76 | 13.17% | 16.5K | $23.1M | $3.66$42.12 |
Related Articles
Featured Article
This Healthcare Stock Is Up 1,000%, Outpacing Nvidia, Tesla, and Apple Combined
Lawrence Rothman|Oct 21, 2025
Can Oncology Institute's stock continue rewarding investors?
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?
Cory Renauer|Oct 16, 2025
Find out if the deal Omeros announced is enough of a reason to buy this stock.
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts
Cory Renauer|Sep 7, 2025
Experts who follow these stocks think they can fly higher despite already gaining over 100% since the end of July.
Here's Why Everybody's Talking About Scholar Rock Right Now
Cory Renauer|Oct 9, 2024
Successful clinical-trial results recently made Scholar Rock one of the stock market's top performers.
2 Incredible Growth Stocks to Buy Hand Over Fist
George Budwell|May 8, 2024
These two healthcare growth stocks could have a lot more room to run.
Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?
Cory Renauer|Dec 23, 2023
The clinical-stage biotech delivered positive trial results for its new COVID-19 preventative antibody treatment.
2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
Alex Carchidi|Mar 17, 2023
Biotechs are capable of making huge gains in short periods, and they often do.
The CEO of Boston Omaha Owns a 33% Stake in This Microcap Stock
Bram Berkowitz|Jan 13, 2023
Boston Omaha has been very successful in recent years, and looks set to have a bright future.
These 2 Nasdaq Biotech Stocks Are Soaring Wednesday Morning
Dan Caplinger|Mar 30, 2022
Markets looked to take a breather after a huge surge in recent weeks.
Should Adagio Say Goodbye to Its COVID-19 Hopes?
Keith Speights and Brian Orelli, PhD|Jan 1, 2022
The prospects for Adagio's experimental COVID antibody therapy appear to be bleak.
